Daniel J Drucker
@danieljdrucker
A clinician scientist at LTRI @sinaihealth studying GLP-1, diabetes, obesity and the gut endocrine system Proud 🇨🇦Not going anywhere Am 🇮🇱Chai
ID: 292334056
http://glucagon.com 03-05-2011 13:51:01
30,30K Tweet
30,30K Followers
1,1K Following
The remarkable mechanisms of SGLT2 inhibitors #heartdisease A robust specific off-target activation of PANK1 by SGLT2i promoting CoA synthesis and efficient fuel use in human hearts, a likely explanation for the clinical benefits of SGLT2i. biorxiv.org/content/10.110… The Arany lab
